Banyan Biomarkers
San Diego, US · Founded 2010 · Delaware corporation
Founders & leadership
Banyan Biomarkers was founded in 2010 by Ronald Hayes, Ph.D..
RH
Ronald Hayes, Ph.D.Founder
JP
Julie PashkowskyExecutive
HN
Henry NordhoffExecutive
JS
Jackson Streeter, M.D.Executive
TG
Tony GroverExecutive
SR
Steven RichieriExecutive
LD
Luis De TaboadaExecutive
ND
Nancy Denslow, Ph.D.Named on SEC filing
Board
DF
David FlaggBoard director
FS
Frederic SweeneyBoard director
WR
William Roper, Jr.Board director
HB
Herbert BoyerBoard director
Reported raises · per SEC filings
Form D private placements$17.9M disclosed across 4 rounds · 2013–2019
▶$2.3MraisedJun 2020 · 8 investors · BiotechnologyRule 506(b)
▶$2.3MraisedJun 2020 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven RichieriExecutive Officer, Director
- Herbert BoyerDirector
- William Roper, Jr.Director
- Stanford WarshawskyDirector
- Nancy Denslow, PhDDirector
- Henry NordhoffExecutive Officer, Director
- Ronald Hayes, PhDExecutive Officer, Director
- Andrew von Eschenbach, MDDirector
- Andrew ParkerDirector
- Offering amount
- $3M
- Amount sold
- $2.3M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.2MraisedJan 2019 · 13 investors · BiotechnologyRule 506(b)
▶$2.2MraisedJan 2019 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nancy Denslow, PhDDirector
- Stanford WarshawskyDirector
- Steven RichieriExecutive Officer, Director
- Julie PashkowskyExecutive Officer
- William Roper, Jr.Director
- Ronald Hayes, PhDExecutive Officer, Director
- Henry NordhoffExecutive Officer, Director
- Herbert BoyerDirector
- Tony GroverExecutive Officer
- Michael Catania, PhDExecutive Officer
- Andrew von Eschenbach, MDDirector
- Offering amount
- $5M
- Amount sold
- $2.2M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.4MraisedFeb 2017 · 16 investors · BiotechnologyRule 506(b)
▶$11.4MraisedFeb 2017 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ronald Hayes, Ph.D.Executive Officer, Director, Promoter
- Frederic SweeneyDirector
- William Roper, Jr.Director
- Julie PashkowskyExecutive Officer
- Henry NordhoffExecutive Officer, Director
- Herbert BoyerDirector
- Jackson Streeter, M.D.Executive Officer, Director
- Nancy Denslow, Ph.D.Director
- Stanford WarshawskyDirector
- Tony GroverExecutive Officer
- Andrew von Eschenbach, M.D.Director
- Steven RichieriExecutive Officer, Director
- Offering amount
- $12M
- Amount sold
- $11.4M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedFeb 2014 · 6 investors · BiotechnologyRule 506(b)
▶$2MraisedFeb 2014 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew von Eschenbach, M.D.Director
- Steven RichieriExecutive Officer
- David FlaggDirector
- Luis De TaboadaExecutive Officer
- Henry NordhoffDirector
- Tony GroverExecutive Officer
- Julie PashkowskyExecutive Officer
- Jackson Streeter, M.D.Executive Officer, Director
- Nancy Denslow, Ph.D.Director
- Stanford WarshawskyDirector
- Ronald Hayes, Ph.D.Executive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Banyan Biomarkers?
- Banyan Biomarkers was founded by Ronald Hayes, Ph.D. in 2010.
- How much funding has Banyan Biomarkers raised?
- Banyan Biomarkers has disclosed $17.9M raised across 4 rounds.
- Where is Banyan Biomarkers headquartered?
- Banyan Biomarkers is headquartered in San Diego, US.